መነሻ › የኤንዶሜትሪየም ካንሰር › ጆርጂያ › Atlanta
በAtlanta፣ GA ለየኤንዶሜትሪየም ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለየኤንዶሜትሪየም ካንሰር የሚደረጉ 17 ጥናቶች በAtlanta እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- እና 1 ተጨማሪ
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Winship Cancer Institute of Emory University, Atlanta
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Emory Winship Cancer Institute, Atlanta
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Piedmont Healthcare, Atlanta
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Piedmont Hospital, Atlanta
- እና 3 ተጨማሪ
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Emory University School of Medicine - Winship Cancer Institute, Atlanta
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Emory Winship Cancer Inst., Atlanta
- Emory Winship Cancer Inst., Atlanta
- Northside Hospital Atlanta, Atlanta
- እና 1 ተጨማሪ
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Emory University, Atlanta
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Winship Cancer Institute, Emory University, Atlanta
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Emory University, Atlanta
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Winship Cancer Institute of Emory University, Atlanta
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Winship Cancer Institute, Emory University, Atlanta
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Winship Cancer Institute, Emory University, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massive Bio SYNERGY-AI site, Atlanta
A Beta-only IL-2 ImmunoTherapY Study
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Emory - Winship Cancer Institute, Atlanta
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Northside Hospital, Atlanta
በሌሎች ከተሞች ለየኤንዶሜትሪየም ካንሰር የሚደረጉ ጥናቶች
- Houston, TX68 ጥናቶች
- New York City, NY52 ጥናቶች
- Boston, MA50 ጥናቶች
- Arlington, VA39 ጥናቶች
- Nashville, TN38 ጥናቶች
- Los Angeles, CA34 ጥናቶች
- St. Louis, MO29 ጥናቶች
- Philadelphia, PA28 ጥናቶች
- San Antonio, TX27 ጥናቶች
- Columbus, OH25 ጥናቶች
- Oklahoma City, OK25 ጥናቶች
- Chicago, IL25 ጥናቶች
በAtlanta ውስጥ ያሉ ሌሎች ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)49 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር47 ጥናቶች
- Multiple Myeloma42 ጥናቶች
- የጡንቻ ካንሰር41 ጥናቶች
- የፕሮስቴት ካንሰር33 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ31 ጥናቶች
- የእንቁላል ካንሰር29 ጥናቶች
- የኮሎሬክታል ካንሰር29 ጥናቶች
- የሳንባ ካንሰር29 ጥናቶች
- Metastatic Cancer28 ጥናቶች
- ዋና የድንጋጠ መዳከም ችግር25 ጥናቶች
- የልብ ድካም25 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።